Aehr Test Systems (AEHR) has secured a silicon photonics production order, marking a meaningful step in the company's effort to diversify beyond silicon carbide (SiC) power device testing, which has been its primary revenue driver. The headline is light on specifics — no customer name, no dollar value, and no delivery timeline have been disclosed publicly.

The backdrop is challenging: Aehr's most recent fiscal year (ending May 2025) showed revenues of $59M, down nearly 11% year-over-year, with the company running a negative net margin of -6.6% and diluted EPS of -$0.13. Gross margins at ~40% remain respectable for a capital equipment name, but the top-line deterioration reflects a slowdown in SiC customer capex.

Silicon photonics is a genuine growth vector — driven by AI data center interconnect demand and co-packaged optics — and Aehr's wafer-level test-and-burn-in expertise is architecturally relevant. A production order (vs. an evaluation or qualification order) is a positive signal, as it implies a customer has cleared the qualification gate and is committing to volume.

The bull case hinges on whether silicon photonics becomes a meaningful revenue contributor fast enough to offset SiC headwinds and restore growth. The bear case is that with no disclosed financials around the order, it could be a small pilot that moves little, while the core business continues to drag on results.

Key things to watch: any customer or volume disclosure, next quarterly earnings for revenue guidance revision, and broader silicon photonics capex signals from hyperscalers and optical module makers.